Publicacións en colaboración con investigadores/as de Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (53)

2023

  1. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries

    Archivos de Bronconeumologia, Vol. 59, Núm. 10, pp. 688-690

  2. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  3. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  4. First-Line Versus Second-Line Use of Reslizumab in Severe Uncontrolled Asthma

    Journal of Investigational Allergology and Clinical Immunology

  5. Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study

    Journal of Medical Virology, Vol. 95, Núm. 7

  6. Persistent COVID in 2023: definition and mechanisms

    Revista de Patologia Respiratoria

  7. Redefining the Role of Bronchoscopy in the Workup of Severe Uncontrolled Asthma in the Era of Biologics: A Prospective Study

    Chest, Vol. 164, Núm. 4, pp. 837-845

  8. Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13

  9. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids

    Chest, Vol. 164, Núm. 3, pp. 606-613

  10. The role of precision medicine in bronchiectasis: emerging data and clinical implications

    Expert Review of Respiratory Medicine, Vol. 17, Núm. 4, pp. 279-293